Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Genetic Disorder
Recent news which mentions Genetic Disorder
Quoin Outlicenses Lead Asset For Skin Disorder In Middle East, North Africa
November 11, 2021
Tickers
QNRX
Tags
Biotech
Contracts
Health Care
From
Benzinga
Quoin, AFT Pharmaceuticals Ink Licensing Pact For Lead Candidate In Genetic Skin Disease
November 08, 2021
Tickers
QNRX
Tags
Market News
Benzinga
Contracts
From
Benzinga
Jennifer Doudna Spinout Mammoth Inks $700M CRISPR Deal With Vertex
October 26, 2021
Tickers
VRTX
Tags
Health Care
General
Genetic Disorder
From
Benzinga
Stealth Bio Stock Falls On FDA Refusal to File Letter For Barth Syndrome Candidate
October 20, 2021
Tickers
MITO
Tags
Short Ideas
General
MITO
From
Benzinga
PTC Therapeutics' Rare Genetic Disease Gene Therapy Shows Durable Improvement Even At 5 Years
September 29, 2021
Tickers
PTCT
Tags
General
Health Care
Genetic Disorder
From
Benzinga
Eli Lilly Inks Another RNA Collab, This Time With ProQR
September 09, 2021
Tickers
LLY
PRQR
Tags
General
Movers
PRQR
From
Benzinga
AstraZeneca's Drug Shows Promise In Copper Build-Up Genetic Disease
August 26, 2021
Tickers
AZN
AZNCF
Tags
Health Care
General
Phase 3 Trial
From
Benzinga
Stealth Bio Files US Application For Ultra Rare Genetic Disease Candidate
August 24, 2021
Tickers
MITO
Tags
Health Care
MITO
General
From
Benzinga
PTC Therapeutics' Waylivra Scores Approval In Brazil For Genetic Disorder
August 24, 2021
Tickers
IONS
PTCT
Tags
FDA
Benzinga
Market News
From
Benzinga
Cyclo Therapeutics' Trappsol Shows Early Safety, Efficacy In Genetic Disorder
July 30, 2021
Tickers
CYTH
Tags
Benzinga
CYTH
Market News
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.